Medigene AG (WBO:MDG1) Price-to-Tangible-Book : 3.39 (As of May. 12, 2024)

View and export this data going back to 2017. Start your Free Trial

What is Medigene AG Price-to-Tangible-Book?

As of today (2024-05-12), Medigene AG's share price is €1.47. Medigene AG's Tangible Book per Share of Dec. 2023 for the quarter that ended in Dec. 2023 was €0.43. Hence, Medigene AG's Price to Tangible Book Ratio of today is 3.39.

The historical rank and industry rank for Medigene AG's Price-to-Tangible-Book or its related term are showing as below:

WBO:MDG1' s Price-to-Tangible-Book Range Over the Past 10 Years
Min: 1.82 Med: 3.68 Max: 4.96
Current: 3.34

During the past 13 years, Medigene AG's highest Price to Tangible Book Ratio was 4.96. The lowest was 1.82. And the median was 3.68.

WBO:MDG1's Price-to-Tangible-Book is ranked worse than
58.07% of 1221 companies
in the Biotechnology industry
Industry Median: 2.7 vs WBO:MDG1: 3.34

A closely related ratio is called PB Ratio. As of today, Medigene AG's share price is €1.47. Medigene AG's Book Value per Sharefor the quarter that ended in Dec. 2023 was €0.81. Hence, Medigene AG's P/B Ratio of today is 1.81.

Medigene AG Price-to-Tangible-Book Historical Data

The historical data trend for Medigene AG's Price-to-Tangible-Book can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medigene AG Price-to-Tangible-Book Chart

Medigene AG Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Price-to-Tangible-Book

Get a 7-Day Free Trial

2.13

4.04

4.73

1.86

3.41

Medigene AG Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Price-to-Tangible-Book	Get a 7-Day Free Trial															4.73	1.95	1.86	2.34	3.41

Competitive Comparison of Medigene AG's Price-to-Tangible-Book

For the Biotechnology subindustry, Medigene AG's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Medigene AG's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Medigene AG's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Medigene AG's Price-to-Tangible-Book falls into.

Medigene AG Price-to-Tangible-Book Calculation

Medigene AG's price-to-tangible-book ratio for today is calculated as:

Price to Tangible Book	=	Share Price	/	Tangible Book per Share (Q: Dec. 2023 )
	=	1.47	/	0.434
	=	3.39

It can also be calculated from the numbers for the whole company:

Price to Tangible Book	=	Market Cap	/	Tangible Equity
	=	Market Cap	/	(Total Stockholders Equity	-	Preferred Stock	-	Intangible Assets)

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Medigene AG Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Medigene AG's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Medigene AG (WBO:MDG1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Medigene AG (WBO:MDG1) » Definitions » Price-to-Tangible-Book

Comparable Companies

Traded in Other Exchanges

MDGEF:USA MDG1:Germany

Address

Lochhamer Strasse 11, Martinsried, Planegg, BY, DEU, 82152

Website

https://www.medigene.com

Medigene AG is an immuno-oncology biotechnology company. focused on developing differentiated T Cell Receptor engineered T cell (TCR-T) therapies for the treatment of multiple solid tumor indications with a high unmet medical need. The operating segments of the organization are Immunotherapies and Other products. Immunotherapies consist of T-cell receptor-based adoptive T-cell therapy and DC vaccines. The group operates in the United States, Germany, and Asia, of which the majority of the revenue is derived from operations in Germany.

Medigene AG (WBO:MDG1) Headlines

No Headlines